Navigation Links
Kaden Commits to Address New Hampshire’s Opioid Epidemic
Date:11/14/2019

Kaden, the digital behavioral health company (formerly known as Thrivee), announced today its commitment to address the opioid addiction crisis in New Hampshire. The company is exploring a collaborative effort with Catholic Medical Center (CMC) to provide support and resources desperately needed by those struggling with opioid use disorder in the state.

Kaden is pleased to be a sponsor of CMC’s 5th Annual Summit: Management of the Opioid-Dependent Patient, taking place Friday, November 15, in Nashua, NH. This annual conference highlights the latest strategies and partnerships in the prevention, identification, and treatment of opioid-dependent patients, serving as an ideal venue to educate providers about Kaden’s groundbreaking virtual treatment services.

“We’re proud to be part of CMC’s efforts to provide individuals struggling with opioid addiction greater access to support and services,” said Dave Henderson, CEO of Kaden. “New Hampshire is the ideal setting to launch this platform, which will give patients real hope for recovery.”

Kaden’s Virtual Medication Assisted Treatment (vMAT) platform is a fully-integrated approach to treat those suffering from opioid use disorder, based on the gold standard of Medication Assisted Treatment. Leveraging virtual technology, the Kaden provider-practices in each state allow patients who have begun Medication Assisted Treatment at the hospital to access ongoing services and support via a smartphone, tablet or PC. The approach is convenient, intuitive and ultimately effective for long-term success relative to traditional treatment methods. Kaden’s platform integrates all aspects of the patient’s therapy and medical care and supports the patient with a concierge Patient Advocate available at any point along their treatment journey.

Kaden’s coordinated approach is centered, from the first in-person visit with a medical professional through all succeeding virtual visits and therapy, on the Kaden Technology Platform. This leading-edge intuitive interface allows the patient, therapist, medical prescriber, and the advocate all to communicate and collaborate in ways that ultimately help the patient to reclaim a healthy, productive lifestyle.

This release is for informational purposes only, and no offer regarding the solicitation of the purchase or sale of any security or securities product is made hereby.

For more information visit http://www.kadenhealth.com and http://www.catholicmedicalcenter.org.

About Kaden:
Based in New York City, Kaden is a behavioral health company dedicated to solving the greatest healthcare challenges of our time with ground-breaking technology and unwavering humanity. Kaden’s first product tackles the opioid addiction crisis by positively influencing human behavior and making advanced technologies and proven treatments accessible to all so that no one has to fight opioid or any addiction alone.

Company Contacts:
Kaden Sales and Business Development: Randy Ringpfiel -- randyr@kadenhealth.com
Kaden Marketing and Public Relations: Marc Warner -- marcw@kadenhealth.com

Read the full story at https://www.prweb.com/releases/kaden_commits_to_address_new_hampshires_opioid_epidemic/prweb16722088.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Dominick Vietri Joins Ancillare as New President; Commits to Building High-Performance Organization
2. Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day
3. Foundation Venture Capital Group commits up to $500,000 in start-up advancing technology platform for tissue visualization
4. Henry Schein Commits $350,000 In Health Care Products To World Vision For Refugee Relief Efforts
5. IFRA Commits to Integrate Non Animal Data in Skin Sensitization Risk Assessment
6. CVS/pharmacy commits to Creating Safer Communities Through Multiple Prescription Drug Abuse Prevention Efforts
7. Lilly commits 780,000 additional vials of insulin to Life for a Child
8. Mezzion Pharma Commits To Phase 3 Clinical Trials Of Udenafil In Adolescents With A Single Functional Ventricle That Have Undergone Fontan Surgical Palliation
9. Alchem International Commits to Tropane Alkaloid APIs and Extends Production and Regulatory Support to Resolve Supply Gap
10. Cadence Health Foundation Commits $3.1 million To Support Services At Central DuPage Hospital and Delnor Hospital
11. American Capital Commits $391 Million in the Combination of Cambridge Major Laboratories and AAIPharma Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2019)... ... December 04, 2019 , ... Tenex ... minimally invasive technologies to treat chronic pain in soft and hard tissue, recently ... TX® technology. , Dr. Bernard Morrey, Chief Medical Officer of Tenex ...
(Date:12/2/2019)... ... December 02, 2019 , ... A ... for Michael, an intensive mental health facility, announced it has named Tim Ryan ... business development and national advocacy efforts. , "We are proud to announce that ...
(Date:12/2/2019)... ... December 02, 2019 , ... ... places to live, work, learn, and play. Striving to fulfill their crucial mission, ... rigorous national standards set by the Public Health Accreditation Board (PHAB). Today, PHAB ...
Breaking Medicine Technology:
(Date:12/4/2019)... ... December 04, 2019 , ... Eolas Therapeutics Inc. today ... use and dependence. The study will investigate safety and pharmacokinetics (PK) of AZD4041 ... orexin-1 (hypocretin-1) receptors that is being developed in collaboration with AstraZeneca. , “Smoking-related ...
(Date:12/2/2019)... , ... December 02, 2019 , ... ... solutions, has worked with EMD Serono, the North American branch of the healthcare ... . This site is designed to educate and inform patients, caregivers, the public, ...
(Date:12/2/2019)... , ... December 02, 2019 , ... ... efficiency and flexibility to the Sterile Processing Department. The elegant design provides a ... The P1000 has downward sliding doors that allow for manual loading that provides ...
(Date:11/30/2019)... ... November 28, 2019 , ... Planet 13 , a ... and dispensary operations, has received a Clio Cannabis Award in Brand Design for ... great accomplishment for our company and also for the talented creative team who ...
(Date:11/30/2019)... ... November 29, 2019 , ... As Cumberland ... teachers aren’t focusing on the potential for academic backslide but rather opportunities for ... textbooks or logging into GoogleClassroom as often during the break but might be ...
Breaking Medicine News(10 mins):